KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Cash from Operations: 2009-2025

Historic Cash from Operations for National Health Investors (NHI) over the last 15 years, with Jun 2025 value amounting to $59.8 million.

  • National Health Investors' Cash from Operations fell 1.52% to $59.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $212.5 million, marking a year-over-year increase of 3.92%. This contributed to the annual value of $207.8 million for FY2024, which is 12.64% up from last year.
  • Per National Health Investors' latest filing, its Cash from Operations stood at $59.8 million for Q2 2025, which was up 28.70% from $46.5 million recorded in Q1 2025.
  • National Health Investors' 5-year Cash from Operations high stood at $60.7 million for Q2 2024, and its period low was $31.0 million during Q1 2023.
  • Its 3-year average for Cash from Operations is $49.9 million, with a median of $50.1 million in 2023.
  • In the last 5 years, National Health Investors' Cash from Operations plummeted by 32.04% in 2022 and then surged by 31.50% in 2024.
  • Quarterly analysis of 5 years shows National Health Investors' Cash from Operations stood at $53.4 million in 2021, then declined by 13.12% to $46.4 million in 2022, then rose by 14.77% to $53.2 million in 2023, then climbed by 8.21% to $57.6 million in 2024, then fell by 1.52% to $59.8 million in 2025.
  • Its last three reported values are $59.8 million in Q2 2025, $46.5 million for Q1 2025, and $57.6 million during Q4 2024.